← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Veriskin, Inc.
San Diego, CA
$6,874,193
Total funding
2
Grants
Funding over time
peak $1.5M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,874,193 · 2
By mechanism
R44$6,874,193 · 2
Investigators at Veriskin, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$1,499,425
R44 · FY2022 · CA
Clinical performance of hemodynamics-based non-invasive device for skin cancer testing$1,164,975
R44 · FY2020 · CA
Hemodynamic Noninvasive Skin Cancer Diagnostics$896,930
R44 · FY2017 · CA
Clinical performance of hemodynamics-based non-invasive device for skin cancer testing$833,460
R44 · FY2021 · CA
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$757,314
R44 · FY2023 · CA
Pivotal Clinical Study of the TruScore Device for Non-Invasive Skin Cancer Diagnostics$742,845
R44 · FY2024 · CA
Hemodynamic Noninvasive Skin Cancer Diagnostics$521,409
R44 · FY2016 · CA
Hemodynamic Noninvasive Skin Cancer Diagnostics$455,835
R44 · FY2016 · CA
Hemodynamic Noninvasive Skin Cancer Diagnostics$2,000
R44 · FY2018 · CA